Lamictal News
Sector Snap: Drug Prices Up in February - CNNMoney.com
GlaxoSmithKline PLC lifted the prices of six drugs, including its seizure treatment Lamictal and antidepressant Wellbutrin. Marsh said the company usually ...
Mutiple pets seized from Lake Jackson home - Brazosport Facts (subscription)
“They (also) found a prescription bottle that contained 27 tablets that were later identified as 20 Lamictal, two Vicodin and five Lexapro,” he said. ...
Mylan Swings to a Loss on Acquisition Costs - Wall Street Journal
Mylan has a number of promising drugs in the pipeline, including a generic version of GlaxoSmithKline PLC's Lamictal tablets, an epilepsy drug with US sales ...
Mylan Posts Q3 Loss On Acquisition Costs; To Sell Nebivolol Rights ... - RTT News
Mylan has several drugs in the pipeline, including a generic version of GlaxoSmithKline PLC's Lamictal tablets. Lamictal is an epilepsy drug that had sales ...
Bear Stearns Lifts Valeant's Sell Rating - Houston Chronicle
... by 2012 as many branded drugs such as Johnson & Johnson's Topimax, Abbott Labs' Depokote ER and GlaxoSmithKline's Lamictal lose patent protection. ...
UBS Ups Glaxo Shares on Valuation - Houston Chronicle
In a note to clients, he said GlaxoSmithKline will be pressured in 2008 by further generic intrusions on anticonvulsant Lamictal and antidepressant ...
Bear Stearns Lifts Valeant's Sell Rating - Houston Chronicle
... by 2012 as many branded drugs such as Johnson & Johnson's Topimax, Abbott Labs' Depokote ER and GlaxoSmithKline's Lamictal lose patent protection. ...
UBS Ups Glaxo Shares on Valuation - Houston Chronicle
In a note to clients, he said GlaxoSmithKline will be pressured in 2008 by further generic intrusions on anticonvulsant Lamictal and antidepressant ...
Glaxo Fourth-Quarter Profit Fell 10% on Avandia Sales (Update6) - Bloomberg
Another five of Glaxo's best-selling medicines will lose patent protection in 2008: Lamictal for epilepsy, antidepressants Wellbutrin XL and Paxil CR, ...
Glaxo's quarterly earnings drop 10% - Philadelphia Inquirer
At the same time, five medicines will lose patent protection this year: Lamictal for epilepsy, the antidepressants Wellbutrin XL and Paxil CR, the migraine ...
Lamictal RSS Feed